Cette traduction est en cours de préparation. En attendant, nous affichons temporairement la version originale en anglais.
Entreprise · 20/07/20181 min de lecture
Metered Dose Inhaler and Dry Powder Inhaler Drug Products-Quality Considerations; Draft Guidance for Industry; Reopening of the Comment Period
Traduction automatique locale · Langue originale de la source
Résumé
The Food and Drug Administration (FDA, Agency, or we) is reopening the comment period for the "Metered Dose Inhaler and Dry Powder Inhaler Drug Products--Quality Considerations; Draft Guidance for Industry," published in the Federal Register of April 19, 2018. FDA is reopening the comment period to allow interested persons additional time to submit comments.
Langue originale de la source: Federal Register — Food and Drug AdministrationOuvrir le communiqué original →